Skip to main content
. 2018 Sep 11;14:1691–1700. doi: 10.2147/TCRM.S173041

Figure 6.

Figure 6

Kaplan–Meier plots of progression-free survival in the full analytical set of patients with advanced pancreatic cancer who continued to receive the PD-1/PD-L1 inhibitor after the failure of PD-1/PD-L1 treatment.